Cantor Fitzgerald Raises Gilead Sciences Price Target to $175
Cantor Fitzgerald maintained its Overweight rating and raised its price target to $175 from $155.
Cantor Fitzgerald maintained its Overweight rating and raised its price target to $175 from $155.